Share Price | Mahamaya Lifesciences Ltd Stock Analysis & Recommendation

Q: Why is Mahamaya Lifesciences Ltd falling/rising?

As of 17-Jul, Mahamaya Lifesciences Ltd's stock price is falling, currently at 163.00, which reflects a decrease of 1.9 or 1.15%. The stock has been on a downward trend, having lost 1.69% over the last two days. This decline is further supported by its performance over the past week and month, where it has fallen by 1.81% and 8.30%, respectively, while the benchmark Sensex has shown positive returns of 0.75% and 1.29% during the same periods.Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Investor participation has also decreased, with a delivery volume of 4.8k on 16 July, which is down by 23.08% compared to the 5-day average. This decline in trading activity suggests reduced interest from investors, contributing to the stock's falling price. Overall, these factors indicate that Mahamaya Lifesciences Ltd is experiencing a downward movement in its stock price.

Q: How big is Mahamaya Lifesc.?

As of 10th June, Market Cap: Mahamaya Lifesciences Ltd has a market capitalization of 414.00 Cr, categorizing it as a Micro Cap company.Recent Quarterly Performance: There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit.Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 49.42 Cr and Total Assets valued at 188.35 Cr.

Q: Who are the peers of the Mahamaya Lifesc.?

Peers: The peers of Mahamaya Lifesc. are Punjab Chemicals, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Scienc, Aristo Bio-Tech, and Dhansa Labs.Quality Snapshot: Excellent management risk is observed at Dharmaj Crop and Bhaskar Agrochem, while Good management risk is found at Best Agrolife. Average management risk is present at Punjab Chemicals, Heranba Inds, Crop Life Scienc, Aristo Bio-Tech, and the rest. Below Average management risk is noted at Shivalik Rasayan and Dhansa Labs. Growth is classified as Excellent for Dharmaj Crop, Good for Bhaskar Agrochem and Best Agrolife, Average for Aristo Bio-Tech, and Below Average for Punjab Chemicals, Heranba Inds, Crop Life Scienc, Shivalik Rasayan, and Dhansa Labs. Capital Structure is rated as Excellent for Dharmaj Crop and Shivalik Rasayan, Good for Punjab Chemicals and Bhaskar Agrochem, Average for Heranba Inds, Best Agrolife, and Aristo Bio-Tech, and Below Average for Crop Life Scienc and Dhansa Labs.Return Snapshot: The peer with the highest 1-year return is Bhaskar Agrochem at 28.03%, while the lowest is Heranba Inds at -32.49%. Mahamaya Lifesc.'s 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Heranba Inds, Best Agrolife, Shivalik Rasayan, and Dhansa Labs.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.4 k (-61.54%) Volume

Shareholding (Mar 2026)

FII

4.77%

Held by 4 FIIs

DII

2.52%

Held by 0 DIIs

Promoter

56.35%

Why is Mahamaya Lifesciences Ltd falling/rising?

18-Jul-2026

As of 17-Jul, Mahamaya Lifesciences Ltd's stock price is declining, currently at 163.00, reflecting a 1.15% decrease. The stock has shown a consistent downward trend, trading below its moving averages and experiencing reduced investor interest.

View full answer

Which are the latest news on Mahamaya Lifesc.?

18-Jul-2026

When is the next results date for Mahamaya Lifesciences Ltd?

How big is Mahamaya Lifesc.?

11-Jun-2026

As of 10th June, Mahamaya Lifesciences Ltd has a market capitalization of 414.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit.

View full answer

Who are the peers of the Mahamaya Lifesc.?

11-Jun-2026

Mahamaya Lifesc.'s peers include Punjab Chemicals, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, Bhaskar Agrochem, Crop Life Science, Aristo Bio-Tech, and Dhansa Labs. Key performance metrics show varying management risks, growth rates, and capital structures among these companies, with Bhaskar Agrochem achieving the highest 1-year return at 28.03% and Heranba Inds the lowest at -32.49%.

View full answer

When is the next results date for Mahamaya Lifesciences Ltd?

21-May-2026

The next results date for Mahamaya Lifesciences Ltd is 25 May 2026.

View full answer

Compare Mahamaya Lifesc. with Similar Stocks

Best Agrolife Shivalik Rasayan Advance Agrolife

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pesticides & Agrochemicals

Market cap

INR 386 Cr (Micro Cap)

P/E

23.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.42

Return on Equity

13.63%

Price to Book

3.15

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-6.21%

6 Months

-9.44%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Mahamaya Lifesc. for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Mahamaya Lifesciences Ltd?

The next results date for Mahamaya Lifesciences Ltd is scheduled for 25 May 2026....

Read full news article

Announcements

Non-Applicability Of The Compliance On Corporate Governance

10-Jul-2026 | Source : BSE

Submission of Non-applicability of the Compliance on Corporate Governance as required under Regulation 27(2) of SEBI (LODR) Regulations 2015

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Jul-2026 | Source : BSE

Certificate under Reg. 74 (5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended on June 30 2026.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

26-May-2026 | Source : BSE

Submission of Press Release on Audited Financial Results for FY26

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

3.07

Debt to EBITDA (avg)

2.69

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.54

Tax Ratio

30.54%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

7.30%

ROCE (avg)

18.08%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.11

EV to EBIT

13.76

EV to EBITDA

12.84

EV to Capital Employed

2.49

EV to Sales

1.31

PEG Ratio

Dividend Yield

ROCE (Latest)

18.08%

ROE (Latest)

13.63%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

KST

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (4.77%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

10.65%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "165.90",
          "val2": "163.39",
          "chgp": "1.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.38",
          "val2": "15.43",
          "chgp": "12.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.29",
          "val2": "3.85",
          "chgp": "11.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.15",
          "val2": "8.37",
          "chgp": "-2.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.48%",
          "val2": "9.46%",
          "chgp": "1.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "329.28",
          "val2": "265.75",
          "chgp": "23.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.51",
          "val2": "24.41",
          "chgp": "37.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.14",
          "val2": "6.81",
          "chgp": "19.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.52",
          "val2": "12.81",
          "chgp": "28.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.19%",
          "val2": "9.24%",
          "chgp": "0.95%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Consolidated) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

165.90

163.39

1.54%

Operating Profit (PBDIT) excl Other Income

17.38

15.43

12.64%

Interest

4.29

3.85

11.43%

Exceptional Items

0.00

Consolidate Net Profit

8.15

8.37

-2.63%

Operating Profit Margin (Excl OI)

10.48%

9.46%

1.02%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 1.54% vs 11.69% in Sep 2025

Consolidated Net Profit

Growth in half year ended Mar 2026 is -2.63% vs 15.45% in Sep 2025

All Half Yearly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

329.28

265.75

23.91%

Operating Profit (PBDIT) excl Other Income

33.51

24.41

37.28%

Interest

8.14

6.81

19.53%

Exceptional Items

0.00

Consolidate Net Profit

16.52

12.81

28.96%

Operating Profit Margin (Excl OI)

10.19%

9.24%

0.95%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 23.91% vs 64.48% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 28.96% vs 145.40% in Mar 2025

All Annual Results

Company CV

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd

Micro Cap

Pesticides & Agrochemicals

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.

Company Coordinates

No Company Details Available